You're Eating Enough Manganese. Your Genes May Still Be Starving You.

Your VDR gene produces the vitamin D receptor, a protein that sits on the surface of your intestinal cells and controls how efficiently they absorb minerals, including manganese. When vitamin D binds to this receptor, it signals your gut to increase absorption of manganese, calcium, magnesium, and phosphorus. Without a functional VDR, your intestines simply do not pull minerals out of food efficiently, no matter how much you consume.

If you carry certain VDR variants, particularly the FokI or BsmI polymorphisms, your intestinal cells respond less effectively to vitamin D signaling. Roughly 30 to 50 percent of the population carries at least one VDR variant. People with VDR variants often experience functional mineral deficiency despite adequate dietary intake and normal vitamin D blood levels. Your vitamin D supplement might raise your blood level, but your intestinal cells still aren’t responding the way they should, and mineral absorption stays suppressed.

You notice this as weak bones despite supplementing, slow wound healing that baffles your doctor, nails that break easily, or joint pain that doesn’t respond to rest. Your body is literally struggling to pull manganese and other minerals out of food and into circulation. You can feel depleted despite eating well and trying to do everything right.

Your HFE gene regulates hepcidin, a hormone that controls iron absorption in your intestines. But hepcidin doesn’t just control iron. It also regulates zinc, copper, and manganese absorption. When hepcidin is dysregulated, your body struggles to absorb multiple minerals simultaneously. The H63D variant of HFE, carried by roughly 15 to 20 percent of people with European ancestry, is associated with mild iron dysregulation and impaired hepcidin signaling.

The consequences ripple through your mineral metabolism. If your HFE is dysregulated, manganese competes with iron and zinc for the same absorption pathways, and all three minerals end up depleted. Your doctor might run an iron panel and see that your ferritin is low, so they recommend iron supplementation. But they miss the manganese piece entirely. You start taking iron, it doesn’t fully absorb, and you’re now even more depleted in manganese because the iron is blocking it from being absorbed.

You experience fatigue that’s worse than low iron alone can explain, bone pain, weak joints, slow healing, and immune dysfunction. The sensation is of being nutritionally exhausted despite eating well and supplementing. Nothing seems to work because you’re trying to fix one mineral deficiency in a system where three minerals are competing for broken absorption pathways.

TMPRSS6 is a gene that encodes matriptase-2, a protease that regulates hepcidin. Where HFE is the broad switch for hepcidin, TMPRSS6 is the dimmer. It fine-tunes how much hepcidin your body produces in response to iron levels. The rs855791 variant of TMPRSS6, found in roughly 45 percent of the population, is associated with lower iron absorption and lower ferritin levels. But again, this isn’t just about iron.

When TMPRSS6 is variant, your body becomes overly aggressive about suppressing mineral absorption as a whole, leaving you depleted in manganese even when your iron is technically adequate. Your hepcidin regulation becomes too tight. Your intestines simply do not let minerals through as easily as they should. You can eat a manganese-rich meal and absorb a fraction of what someone without this variant would absorb. Over months and years, this small difference compounds into real deficiency.

You notice slow wound healing that confuses your doctor, joint pain that gets worse over time, bone density that declines faster than it should, and an immune system that seems to falter more easily than it did before. You might also notice that iron supplements make you feel worse, not better, because you’re already somewhat manganese-depleted and the iron is further blocking manganese absorption.

SLC30A8 encodes a zinc transporter protein that sits on cell membranes and pumps zinc into cells. It’s particularly important in pancreatic beta cells, but this transporter exists throughout your body in any cell that needs zinc. The R325W variant, carrying the W allele in roughly 30 percent of the population, impairs zinc transport efficiency. Here’s what most people miss: zinc transporters don’t just carry zinc. They transport and interact with manganese, cadmium, and other divalent cations. When your SLC30A8 is variant, zinc transport is impaired, and manganese transport suffers alongside it.

Your cells literally cannot pull manganese across the membrane efficiently, even if your intestines absorbed it just fine. Your bloodwork might show adequate manganese levels, but your cells are starving for it because the transporters aren’t working. This is functional deficiency at the cellular level. It’s invisible on standard tests and baffling to doctors who don’t understand gene-nutrient interactions.

You experience poor wound healing, weak joints, bone pain, metabolic slowdown, and immune dysfunction that seems disproportionate to your nutrient intake. You might also notice blood sugar instability because manganese is essential for glucose metabolism. You feel depleted at a level that supplements haven’t touched because the problem isn’t absorption; it’s cellular transport.

MTHFR is the gene that encodes methylenetetrahydrofolate reductase, the enzyme responsible for converting folate into its active, methylated form. This enzyme is fundamental to your methylation cycle, which produces the methyl groups your body needs to regulate literally thousands of biochemical processes. The C677T variant, carried by roughly 40 percent of people with European ancestry, reduces this enzyme’s activity by 40 to 70 percent. This means your cells struggle to produce adequate methylated folate and adequate cofactors for enzyme function.

Manganese is a cofactor for arginase, an enzyme essential for the urea cycle and nitric oxide production. If your MTHFR is variant and your methylation cycle is sluggish, your manganese-dependent enzymes simply cannot function well, even if manganese levels are adequate. You’re not just low in manganese; you’re low in the cellular capacity to use manganese effectively. Your body is trying to run on partial enzyme power.

You experience fatigue that sleep doesn’t touch, brain fog, slow wound healing, joint pain, weak bones, and an immune system that struggles. Supplementing with regular folate won’t help because you can’t convert it efficiently. Your energy production stays sluggish because the manganese-dependent parts of your mitochondrial machinery can’t run at full capacity.

COMT encodes catechol-O-methyltransferase, an enzyme that breaks down dopamine and norepinephrine. If you carry the Met158Val or Val158Met variant, your COMT activity is altered. Fast versions break down these neurotransmitters too quickly; slow versions break them down too slowly. Most people know COMT for its role in stress resilience and focus. What they don’t know is that COMT also regulates how your body handles stress-induced mineral loss. When you’re stressed or your COMT is dysregulated, your body shunts resources away from mineral absorption and toward immediate stress survival.

People with slow COMT variants tend to hold onto minerals better; people with fast COMT variants lose minerals more readily through sweat, urine, and poor absorption during stress. If you have a fast COMT variant and you’re chronically stressed (which many of us are), your body is essentially running a mineral-loss program. Manganese gets depleted more easily. Your zinc and other minerals follow. Supplementing with standard doses simply can’t keep up with the loss rate.

You experience joint pain that worsens under stress, bone density loss that accelerates during difficult periods, slow healing, immune dysfunction, and a sense that your body is just running on empty despite decent nutrition. You might notice that stress management helps more than supplementation, because the real problem is the mineral loss during the stress response itself.